PLX icon

Protalix BioTherapeutics

45 hedge funds and large institutions have $141M invested in Protalix BioTherapeutics in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $159M → $141M (-$18.4M)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

98% less call options, than puts

Call options by funds: $40K | Put options by funds: $2.2M

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$40K
Puts
$2.2M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$39.8M
2
$30M
3
$23.1M
4
$7.78M
5
$6.97M
6
$4.58M
7
$4.46M
8
$4.05M
9
$3.89M
10
$2.72M
11
$2.2M
12
$1.75M
13
$1.7M
14
$1.43M
15
$1.02M
16
$934K
17
$913K
18
$624K
19
$297K
20
$297K
21
$290K
22
$208K
23
$176K
24
$158K
25
$156K